+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

N

Actively Recruiting

Researchers are studying type I interferonopathies, which are rare genetic autoinflammatory disorders mainly affecting children but sometimes adults. These conditions often involve the central nervous system, joints, and occasionally blood abnormalities or immune deficiencies. They are caused by over-activation of the type I interferon pathway and tend to resist standard immunosuppressive treatments. The goal is to better understand the natural course of these diseases and their diverse clinical features. This observational study follows patients with genetically confirmed type I interferonopathies over a long period. It aims to characterize disease progression, identify immune factors linked to specific genotypes, find biomarkers for diagnosis and monitoring, and observe treatment responses based on patient phenotypes and genotypes. The study does not involve experimental treatments but collects data to improve future therapies. Participants will be monitored from 2025 through 2045. Data collection includes tracking disease evolution, immunological profiles, and treatment effectiveness. Researchers aim to clarify pathophysiological mechanisms and patient subgroups to guide personalized treatment options. Participation involves regular evaluations without experimental interventions, contributing to knowledge that supports better clinical trial design and patient care.

All AgesAll Genders
32 locations